T 2517/19 (Site-specific conjugation of drugs to antibodies / BYONDIS) of 22.02.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T251719.20210222
- Date of decision
- 22 February 2021
- Case number
- T 2517/19
- Petition for review of
- -
- Application number
- 15724638.0
- IPC class
- A61K 47/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- SITE-SPECIFIC CONJUGATION OF LINKER DRUGS TO ANTIBODIES AND RESULTING ADCS
- Applicant name
- Byondis B.V.
- Opponent name
- -
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)
- Keywords
- Inventive step - (yes)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent on the basis of the set of claims of the main request filed with the letter dated 24 July 2019 and a description to be adapted thereto.